Novo Nordisk executive Gordon Findlay collapses in front of Donald Trump

Trump (Image: Sky)

The Oval Office has descended into chaos after pharmaceutical executive Gordon Findlay collapsed in front of Donald Trump. The Novo Nordisk exutive collapsed as members of the Trump administration were announcing a new deal for weight-loss medications.

Mr Findlay had been standing behind the president when his knees buckled, and administration officials and pharmaceutical representatives rushed to his side to ease him down to the floor gently. White House Press Secretary Karoline Leavitt confirmed that the person who fainted is "okay" and that the conference would resume.

An official statement said: “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.

"The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”

Reporters who were in the Oval Office at the time, and who were ushered out shortly after, said Dr Mehmet Oz, the administrator of Centers for Medicare and Medicaid Services, helped the executive to the ground to prevent him from hitting his head, and that Cabinet members elevated his legs.

Robert F. Kennedy Junior, President Donald Trump and Dr Mehmet Oz drew their attention to Findlay as the press conference was called to a halt.

The meeting had been called over weight loss medications, to expand coverage and reduce prices for popular treatments used for obesity.

According to CNBC, President Donald Trump announced deals with Eli Lilly and Novo Nordisk that would lower the prices of some of their drugs used to help people manage their weight.

The GLP-1 drug prices will be lowered on Medicare and Medicaid, and the treatments will be offered to consumers directly at a discount on a website set to be launched by the Trump administration in January 2026.